SAb Biotherapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch SAb Biotherapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes (NCT07187531) | SAb Biotherapeutics, Inc. | 2025-11-25 |
| A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo (NCT06435936) | SAb Biotherapeutics, Inc. | 2024-04-22 |
| Study of SAB-176 in Healthy Adult Participants (NCT04850898) | SAb Biotherapeutics, Inc. | 2021-06-23 |
| Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 (NCT04469179) | SAb Biotherapeutics, Inc. | 2020-08-20 |
| Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants (NCT04471038) | SAb Biotherapeutics, Inc. | 2020-07-29 |
| Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants (NCT04468958) | SAb Biotherapeutics, Inc. | 2020-07-01 |
Track SAb Biotherapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.